Table 1 Metabolic parameters at the end of experimental periods

Body weight at fourth week (g)

347 ± 32^a

332 ± 30^a

337 ± 29^a

301 ± 22^b

346 ± 31^a

Body weight at seventh week (g)

332 ± 34^b

328 ± 33^b

329 ± 35^b

297 ± 26^c

367 ± 36^a

Food intake at fourth week (g)

14.8 ± 1.7

14.0 ± 1.5

13.6 ± 2.0

13.1 ± 1.4

14.7 ± 1.8

Food intake at seventh week (g)

13.3 ± 1.6^b

14.3 ± 1.9^ab

14.0 ± 1.8^ab

13.1 ± 1.7^b

15.4 ± 1.7^a

Average intake of supplements (mg/day)

–

57.4 ± 6.5

55.6 ± 6.1

–

–

Peri-uterine fat (g)

7.9 ± 1.1^a

6.1 ± 0.7^b

6.7 ± 0.8^b

4.9 ± 0.9^c

8.4 ± 0.9^a

Retroperitoneum fat (g)

11.7 ± 2.0^a

9.9 ± 1.1^b

7.4 ± 1.0^c

5.8 ± 0.5^d

12.3 ± 1.8^a

Uterine weight (g)

0.17 ± 0.06^b

0.22 ± 0.07^b

0.20 ± 0.05^b

0.51 ± 0.08^a

0.18 ± 0.05^b

Serum 17β-estradiol levels (pg/ml)

1.6 ± 0.6^b

1.8 ± 0.5^b

1.9 ± 0.5^b

7.5 ± 1.1^a

1.7 ± 0.6^b

Serum triglyceride (mg/dL)

85.9 ± 5.3^a

71.9 ± 6.4^b

70.4 ± 7.4^b

68.3 ± 6.6^b

84.3 ± 5.5^a

Serum glucose (mg/dL)

103 ± 8^a

98 ± 7^a

100 ± 8^a

88 ± 10^b

102 ± 7^a

Serum insulin (ng/mL)

1.49 ± 0.17^a

1.21 ± 0.14^b

1.26 ± 0.17^b

1.19 ± 0.11^b

1.43 ± 0.15^a

HOMA-IR

8.5 ± 0.9^a

6.6 ± 0.8^b

6.9 ± 0.9^b

5.8 ± 0.6^c

8.1 ± 0.8^a